FindTrial
Sign In

tDCS as an augmentation strategy for MDD

Transcranial direct current stimulation as an augmentation strategy in Major Depressive Disorder - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088516
Enrollment
40
Registered
2025-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F33- Major depressive disorder, recurrent Health Condition 2: F32- Major depressive disorder, singleepisode

Interventions

Intervention1: NIL: NIL Intervention2: active tdcs arm: Active tDCS given to MDD patients. Control Intervention1: Sham tdcs arm: sham tdcs given to MDD patients.

Sponsors

SN Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All the patients were aged between 18-60 years. 2. Patients diagnosed with a current Major Depressive Episode according to DSM-5TR. 3. Patients giving written informed consent. 4. Drug free (for at least 6 weeks).

Exclusion criteria

Exclusion criteria: 1. Patients having major depressive episodes with psychotic symptoms. 2. Patients with treatment resistant depression. 3. Patients having Bipolar disorder with current episode Depression. 4. Patients with substance use disorders except tobacco and nicotine. 5. Patient having suicidal ideations. 6. Chronic and disabling physical illnesses which need immediate attention(tuberculosis, congestive heart failure, chronic kidney disease, severe respiratory illness).

Design outcomes

Primary

MeasureTime frame
IMPROVEMENT IN HAM-A, MADRSTimepoint: Baseline, 5 days and 14 days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactNIYATI NARANG

SN MEDICAL COLLEGE, AGRA

drvsinh2000@gmail.com7905121209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026